[Diabetic asymmetric proximal neuropathy].

Autor:	Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Rudakova IG; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Isakova EV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Belova YA; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Volchenkova TV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Khirbek M; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Stashuk GA; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2017; Vol. 117 (1), pp. 59-62.
DOI:	10.17116/jnevro20171171159-62
Abstrakt:	Aim: To study the prevalence, clinical features and treatment of diabetic asymmetric proximal neuropathy (DAPN). Material and Methods: Four hundred and forty-five patients with diabetes mellitus (DM), 257 women and 188 men, mean age 47.6±0.5 years, including 163 patients with DM type I and 282 with DM type II, were examined. Results and Conclusion: Distal symmetric sensory motor polyneuropathy was found in 62% of the patients, autonomic neuropathy in 25.6%, somatic mononeuropathy in 28.5%, DAPN in 7.9%. DAPN was more frequent in patients with DM type II (9.6), with poor control of glycemia and DM duration more than 5 years. Pain and paresthesia in a zone of innervation of several roots and nerves, amyotrophy that spread beyond the definite myotome were key symptoms of DAPN. The efficacy of double therapy of neuropathic pain (pregabalin and duloxetine) and vitamin B complex was shown. A role of glucocorticoids and normal human immunoglobulin in treatment of DAPN is discussed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu